Autopsy report · NCT02853604
Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer
Cause of deathNo reason given
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 3 years 8 months before it stopped.
- 110 participants enrolled.
- Results were posted on the registry 3 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Advaxis, Inc.
- Sponsor type
- Industry
- Conditions
- High Risk Cervical Cancer; Advanced Cervical Cancer
- Interventions
- ADXS11-001; Placebo
- Participants
- 110
- Sites
- 117
- Countries
- Argentina, Brazil, Canada, Chile, Malaysia, Mexico, Poland, Russia, Serbia, South Korea, Spain, Taiwan and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.